Interactions between Notch- and hypoxia-induced transcriptomes in embryonic stem cells

Experimental Cell Research

Volumn 316, Issue 9, 2010, Pages 1610-1624

  Main, Heather ^a   Lee, Kian Leong ^b,d   Yang, Henry ^e   Haapa Paananen, Saija ^c   Edgren, Henrik ^c   Jin, Shaobo ^a   Sahlgren, Cecilia ^c   Kallioniemi, Olli ^c   Poellinger, Lorenz ^a,d   Lim, Bing ^b   Lendahl, Urban ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c UNIVERSITY OF TURKU   (Finland)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e AGENCY FOR SCIENCE   (Singapore)

Author keywords

CSL; ES cell; FIH; Gamma secretase; HIF; Micro array; Transcriptome

Indexed keywords

NOTCH RECEPTOR; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; CELL HYPOXIA; CELL INTERACTION; CONTROLLED STUDY; DEVELOPMENTAL BIOLOGY; DISEASE COURSE; EMBRYO; EMBRYONIC STEM CELL; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 77952891757     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.12.012     Document Type: Article

References (57)

1. Hurlbut G.D., Kankel M.W., Lake R.J., Artavanis-Tsakonas S. Crossing paths with Notch in the hyper-network. Curr. Opin. Cell. Biol. 2007, 19:166-175.
2. Kopan R., Ilagan M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009, 137:216-233.
3. Laky K., Fowlkes B.J. Notch signaling in CD4 and CD8 T cell development. Curr. Opin. Immunol. 2008, 20:197-202.
4. Holmberg J., Hansson E., Malewicz M., Sandberg M., Perlmann T., Lendahl U., Muhr J. SoxB1 transcription factors and Notch signaling use distinct mechanisms to regulate proneural gene function and neural progenitor differentiation. Development 2008, 135:1843-1851.
5. Kageyama R., Ohtsuka T., Hatakeyama J., Ohsawa R. Roles of bHLH genes in neural stem cell differentiation. Exp. Cell Res. 2005, 306:343-348.
6. Poellinger L., Lendahl U. Modulating Notch signaling by pathway-intrinsic and pathway-extrinsic mechanisms. Curr. Opin. Genet. Dev. 2008, 18:449-454.
7. Kenneth N.S., Rocha S. Regulation of gene expression by hypoxia. Biochem. J. 2008, 414:19-29.
8. Lendahl U., Lee K.L., Yang H., Poellinger L. Generating specificity and diversity in the transcriptional response to hypoxia. Nat. Rev. Genet. 2009, 10:821-832.
9. Hewitson K.S., McNeill L.A., Riordan M.V., Tian Y.M., Bullock A.N., Welford R.W., Elkins J.M., Oldham N.J., Bhattacharya S., Gleadle J.M., Ratcliffe P.J., Pugh C.W., Schofield C.J. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 2002, 277:26351-26355.
10. Diez H., Fischer A., Winkler A., Hu C.J., Hatzopoulos A.K., Breier G., Gessler M. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp. Cell. Res. 2007, 313:1-9.
11. Patel N.S., Li J.L., Generali D., Poulsom R., Cranston D.W., Harris A.L. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res. 2005, 65:8690-8697.
12. Sahlgren C., Gustafsson M.V., Jin S., Poellinger L., Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6392-6397.
13. Li X., Zhang X., Leathers R., Makino A., Huang C., Parsa P., Macias J., Yuan J.X., Jamieson S.W., Thistlethwaite P.A. Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat. Med. 2009, 15:1289-1297.
14. Bertout J.A., Patel S.A., Fryer B.H., Durham A.C., Covello K.L., Olive K.P., Goldschmidt M.H., Simon M.C. Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model. Cancer Res. 2009, 69:3213-3220.
15. Gustafsson M.V., Zheng X., Pereira T., Gradin K., Jin S., Lundkvist J., Ruas J.L., Poellinger L., Lendahl U., Bondesson M. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell. 2005, 9:617-628.
16. Coleman M.L., McDonough M.A., Hewitson K.S., Coles C., Mecinovic J., Edelmann M., Cook K.M., Cockman M.E., Lancaster D.E., Kessler B.M., Oldham N.J., Ratcliffe P.J., Schofield C.J. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J. Biol. Chem. 2007, 282:24027-24038.
17. Zheng X., Linke S., Dias J.M., Gradin K., Wallis T.P., Hamilton B.R., Gustafsson M., Ruas J.L., Wilkins S., Bilton R.L., Brismar K., Whitelaw M.L., Pereira T., Gorman J.J., Ericson J., Peet D.J., Lendahl U., Poellinger L. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3368-3373.
18. Kyba M., Perlingeiro R.C., Daley G.Q. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002, 109:29-37.
19. Schroeder T., Meier-Stiegen F., Schwanbeck R., Eilken H., Nishikawa S., Hasler R., Schreiber S., Bornkamm G.W., Just U. Activated Notch1 alters differentiation of embryonic stem cells into mesodermal cell lineages at multiple stages of development. Mech. Dev. 2006, 123:570-579.
20. Chapman G., Liu L., Sahlgren C., Dahlqvist C., Lendahl U. High levels of Notch signaling down-regulate Numb and Numblike. J. Cell. Biol. 2006, 175:535-540.
21. Chua S.W., Vijayakumar P., Nissom P.M., Yam C.Y., Wong V.V., Yang H. A novel normalization method for effective removal of systematic variation in microarray data. Nucleic Acids Res. 2006, 34:e38.
22. Miller L.D., Smeds J., George J., Vega V.B., Vergara L., Ploner A., Pawitan Y., Hall P., Klaar S., Liu E.T., Bergh J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13550-13555.
23. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31:e15.
24. Dai M., Wang P., Boyd A.D., Kostov G., Athey B., Jones E.G., Bunney W.E., Myers R.M., Speed T.P., Akil H., Watson S.J., Meng F. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 2005, 33:e175.
25. Eckfeldt C.E., Mendenhall E.M., Verfaillie C.M. The molecular repertoire of the 'almighty' stem cell. Nat. Rev. Mol. Cell. Biol. 2005, 6:726-737.
26. Gaulden J., Reiter J.F. Neur-ons and neur-offs: regulators of neural induction in vertebrate embryos and embryonic stem cells. Hum. Mol. Genet. 2008, 17:R60-66.
27. 2 tensions and the prevention of differentiation of hES cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4783-4788.
28. Hitoshi S., Alexson T., Tropepe V., Donoviel D., Elia A.J., Nye J.S., Conlon R.A., Mak T.W., Bernstein A., van der Kooy D. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev. 2002, 16:846-858.
29. Lowell S., Benchoua A., Heavey B., Smith A.G. Notch promotes neural lineage entry by pluripotent embryonic stem cells. PLoS Biol. 2006, 4:e121.
30. Nemir M., Croquelois A., Pedrazzini T., Radtke F. Induction of cardiogenesis in embryonic stem cells via downregulation of Notch1 signaling. Circ. Res. 2006, 98:1471-1478.
31. Simon M.C., Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat. Rev. Mol. Cell. Biol. 2008, 9:285-296.
32. Ying Q.L., Smith A.G. Defined conditions for neural commitment and differentiation. Methods Enzymol. 2003, 365:327-341.
33. Amarilio R., Viukov S.V., Sharir A., Eshkar-Oren I., Johnson R.S., Zelzer E. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 2007, 134:3917-3928.
34. Hoflinger S., Kesavan K., Fuxa M., Hutter C., Heavey B., Radtke F., Busslinger M. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors. J. Immunol. 2004, 173:3935-3944.
35. Jin S., Hansson E.M., Tikka S., Lanner F., Sahlgren C., Farnebo F., Baumann M., Kalimo H., Lendahl U. Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Circ. Res. 2008, 102:1483-1491.
36. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell. Biol. 2006, 7:678-689.
37. Arnold S.J., Hofmann U.K., Bikoff E.K., Robertson E.J. Pivotal roles for eomesodermin during axis formation, epithelium-to-mesenchyme transition and endoderm specification in the mouse. Development 2008, 135:501-511.
38. Crompton L.A., Roure C.Du, Rodriguez T.A. Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. Dev. Dyn. 2007, 236:3137-3143.
39. Jen Y., Manova K., Benezra R. Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis. Dev. Dyn. 1997, 208:92-106.
40. McKnight K.D., Hou J., Hoodless P.A. Dynamic expression of thyrotropin-releasing hormone in the mouse definitive endoderm. Dev. Dyn. 2007, 236:2909-2917.
41. Wright E., Hargrave M.R., Christiansen J., Cooper L., Kun J., Evans T., Gangadharan U., Greenfield A., Koopman P. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat. Genet. 1995, 9:15-20.
42. Gordan J.D., Simon M.C. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 2007, 17:71-77.
43. Kaelin W.G. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat. Rev. Cancer 2008, 8:865-873.
44. Miele L., Golde T., Osborne B. Notch signaling in cancer. Curr. Mol. Med. 2006, 6:905-918.
45. Kilpinen S., Autio R., Ojala K., Iljin K., Bucher E., Sara H., Pisto T., Saarela M., Skotheim R.I., Bjorkman M., Mpindi J.P., Haapa-Paananen S., Vainio P., Edgren H., Wolf M., Astola J., Nees M., Hautaniemi S., Kallioniemi O. Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol. 2008, 9:R139.
46. Choi S.M., Oh H., Park H. Microarray analyses of hypoxia-regulated genes in an aryl hydrocarbon receptor nuclear translocator (Arnt)-dependent manner. FEBS J. 2008, 275:5618-5634.
47. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., Simon M.C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 2003, 23:9361-9374.
48. Van Elzen R., Moens L., Dewilde S. Expression profiling of the cerebral ischemic and hypoxic response. Expert Rev. Proteomics 2008, 5:263-282.
49. Westfall S.D., Sachdev S., Das P., Hearne L.B., Hannink M., Roberts R.M., Ezashi T. Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. Stem Cells Dev. 2008, 17:869-881.
50. Hu C.J., Iyer S., Sataur A., Covello K.L., Chodosh L.A., Simon M.C. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Mol. Cell Biol. 2006, 26:3514-3526.
51. Holmquist-Mengelbier L., Fredlund E., Lofstedt T., Noguera R., Navarro S., Nilsson H., Pietras A., Vallon-Christersson J., Borg A., Gradin K., Poellinger L., Pahlman S. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell. 2006, 10:413-423.
52. Arboleda-Velasquez J.F., Zhou Z., Shin H.K., Louvi A., Kim H.H., Savitz S.I., Liao J.K., Salomone S., Ayata C., Moskowitz M.A., Artavanis-Tsakonas S. Linking Notch signaling to ischemic stroke. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:4856-4861.
53. Buas M.F., Kabak S., Kadesch T. Inhibition of myogenesis by Notch: evidence for multiple pathways. J. Cell Physiol. 2009, 218:84-93.
54. Krejci A., Bray S. Notch activation stimulates transient and selective binding of Su(H)/CSL to target enhancers. Genes Dev. 2007, 21:1322-1327.
55. Ignatiadis M., Georgoulias V., Mavroudis D. Circulating tumor cells in breast cancer. Curr Opin. Obstet. Gynecol. 2008, 20:55-60.
56. Pece S., Serresi M., Santolini E., Capra M., Hulleman E., Galimberti V., Zurrida S., Maisonneuve P., Viale G., Di Fiore P.P. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J. Cell. Biol. 2004, 167:215-221.
57. Stylianou S., Clarke R.B., Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res. 2006, 66:1517-1525.